New Series of Interactive Cardiology MCQs 16 - All About Cardiovascular System and Disorders

Q1

During simultaneous right and left heart catheterization to differentiate constrictive pericarditis from restrictive cardiomyopathy, what respiratory variation in ventricular pressures is the hallmark of constrictive pericarditis?

Q2

A 40-year-old man with known Brugada syndrome presents to the emergency department. Which of the following acute clinical scenarios is a well-recognized trigger for unmasking the classic Type 1 Brugada ECG pattern and precipitating ventricular fibrillation?

Q3

Based on the landmark COAPT trial, which patient profile with severe functional (secondary) mitral regurgitation derives the greatest mortality and heart failure hospitalization benefit from Transcatheter Edge-to-Edge Repair (TEER / MitraClip)?

Q4

A patient undergoes a Cardiac MRI to evaluate left ventricular hypertrophy. The T1 mapping sequence reveals a significantly lowered native T1 relaxation time. Which restrictive/infiltrative cardiomyopathy is characteristically associated with this specific finding?

Q5

Vericiguat has been approved for high-risk patients with Heart Failure with Reduced Ejection Fraction (HFrEF) following a worsening heart failure event. What is its precise mechanism of action?

Q6

In adult congenital heart disease, Ebstein’s anomaly of the tricuspid valve is highly associated with which specific electrophysiologic condition?

Q7

In evaluating a patient with severe aortic stenosis, the concept of “paradoxical low-flow, low-gradient” aortic stenosis refers to a clinical state with a preserved Ejection Fraction (>= 50%). By definition, what stroke volume index (SVi) cut-off defines the “low-flow” state in this pathology?

Q8

A neonate is born with complete congenital heart block (CHB). Which maternal autoantibodies are most directly implicated in crossing the placenta and destroying the fetal atrioventricular node?

Q9

When applying the Brugada criteria to an ECG showing a wide-complex tachycardia, which is the very first step in determining if the rhythm is Ventricular Tachycardia (VT)?

Q10

In patients with severe Carcinoid Heart Disease, which combination of valvular pathologies is most classically observed on echocardiography?

Q11

A patient with a mechanical bileaflet mitral valve presents for a routine checkup. The patient asks if they can switch from Warfarin to a Direct Oral Anticoagulant (DOAC) like rivaroxaban or dabigatran. According to trials (RE-ALIGN, PROACT Xa), what is the guideline recommendation?

Q12

During pre-procedural CT planning for Transcatheter Aortic Valve Replacement (TAVR), which anatomical combination poses the highest risk for acute coronary artery occlusion during valve deployment?

Q13

In echocardiographic assessment of primary (degenerative) mitral regurgitation, which Vena Contracta width is the established cutoff indicating “severe” MR?

Q14

Ticagrelor is a potent P2Y12 inhibitor used in acute coronary syndromes. Unlike Clopidogrel or Prasugrel, what is its unique pharmacological property?

Q15

A patient with an acute inferior STEMI suddenly develops profound hypotension, a loud holosystolic murmur at the apex, and pulmonary edema. Right heart catheterization shows prominent “v” waves in the pulmonary capillary wedge pressure (PCWP) tracing. What is the diagnosis?

Q16

Patients with a bicuspid aortic valve (BAV) have a high incidence of a concurrent congenital vascular anomaly. Which vascular pathology MUST be aggressively screened for in every patient newly diagnosed with a BAV?

Q17

In patients with severe renal impairment (e.g., GFR

Q18

A patient with non-valvular atrial fibrillation has a high CHA2DS2-VASc score and recurrent severe GI bleeding, prompting consideration for a Left Atrial Appendage (LAA) closure device (e.g., Watchman). What is an absolute anatomical/clinical contraindication to placing this device?

Q19

According to the REDUCE-IT trial, Icosapent ethyl (a highly purified EPA omega-3 fatty acid) is indicated to reduce cardiovascular events in a very specific patient cohort. Which lipid profile parameters identify the appropriate candidate?

Q20

In a patient with cardiac tamponade, what is the pathophysiologic mechanism behind “Pulsus Paradoxus” (an exaggerated drop > 10 mmHg in systolic blood pressure during inspiration)?

Q21

The proteasome inhibitor Carfilzomib, used in the treatment of multiple myeloma, is notoriously associated with which severe cardiovascular toxicity?

Q22

When interpreting the results of an intravascular ultrasound (IVUS) in the Left Main Coronary Artery, what Minimum Lumen Area (MLA) cut-off generally supports the decision to defer percutaneous intervention because the lesion is considered hemodynamically non-significant?

Q23

The presence of “Kussmaul’s Sign” during physical examination (a paradoxical rise in jugular venous pressure during inspiration) is indicative of right heart failure and is classically associated with which condition?

Q24

Mavacamten is a novel, first-in-class therapy FDA-approved for symptomatic Hypertrophic Obstructive Cardiomyopathy (HOCM). What is its specific mechanism of action?

Q25

In the management of Atrial Fibrillation, the CABANA trial compared catheter ablation to medical therapy. What was the primary conclusion regarding mortality and stroke endpoints?

Interactive Cardiology MCQs #16

During simultaneous right and left heart catheterization to differentiate constrictive pericarditis from restrictive cardiomyopathy, what respiratory variation in ventricular pressures is the hallmark of constrictive pericarditis?

A 40-year-old man with known Brugada syndrome presents to the emergency department. Which of the following acute clinical scenarios is a well-recognized trigger for unmasking the classic Type 1 Brugada ECG pattern and precipitating ventricular fibrillation?

Based on the landmark COAPT trial, which patient profile with severe functional (secondary) mitral regurgitation derives the greatest mortality and heart failure hospitalization benefit from Transcatheter Edge-to-Edge Repair (TEER / MitraClip)?

A patient undergoes a Cardiac MRI to evaluate left ventricular hypertrophy. The T1 mapping sequence reveals a significantly lowered native T1 relaxation time. Which restrictive/infiltrative cardiomyopathy is characteristically associated with this specific finding?

Vericiguat has been approved for high-risk patients with Heart Failure with Reduced Ejection Fraction (HFrEF) following a worsening heart failure event. What is its precise mechanism of action?

In adult congenital heart disease, Ebstein’s anomaly of the tricuspid valve is highly associated with which specific electrophysiologic condition?

A neonate is born with complete congenital heart block (CHB). Which maternal autoantibodies are most directly implicated in crossing the placenta and destroying the fetal atrioventricular node?

When applying the Brugada criteria to an ECG showing a wide-complex tachycardia, which is the very first step in determining if the rhythm is Ventricular Tachycardia (VT)?

In patients with severe Carcinoid Heart Disease, which combination of valvular pathologies is most classically observed on echocardiography?

A patient with a mechanical bileaflet mitral valve presents for a routine checkup. The patient asks if they can switch from Warfarin to a Direct Oral Anticoagulant (DOAC) like rivaroxaban or dabigatran. According to trials (RE-ALIGN, PROACT Xa), what is the guideline recommendation?

During pre-procedural CT planning for Transcatheter Aortic Valve Replacement (TAVR), which anatomical combination poses the highest risk for acute coronary artery occlusion during valve deployment?

In echocardiographic assessment of primary (degenerative) mitral regurgitation, which Vena Contracta width is the established cutoff indicating “severe” MR?

Ticagrelor is a potent P2Y12 inhibitor used in acute coronary syndromes. Unlike Clopidogrel or Prasugrel, what is its unique pharmacological property?

A patient with an acute inferior STEMI suddenly develops profound hypotension, a loud holosystolic murmur at the apex, and pulmonary edema. Right heart catheterization shows prominent “v” waves in the pulmonary capillary wedge pressure (PCWP) tracing. What is the diagnosis?

Patients with a bicuspid aortic valve (BAV) have a high incidence of a concurrent congenital vascular anomaly. Which vascular pathology MUST be aggressively screened for in every patient newly diagnosed with a BAV?

In patients with severe renal impairment (e.g., GFR

A patient with non-valvular atrial fibrillation has a high CHA2DS2-VASc score and recurrent severe GI bleeding, prompting consideration for a Left Atrial Appendage (LAA) closure device (e.g., Watchman). What is an absolute anatomical/clinical contraindication to placing this device?

According to the REDUCE-IT trial, Icosapent ethyl (a highly purified EPA omega-3 fatty acid) is indicated to reduce cardiovascular events in a very specific patient cohort. Which lipid profile parameters identify the appropriate candidate?

In a patient with cardiac tamponade, what is the pathophysiologic mechanism behind “Pulsus Paradoxus” (an exaggerated drop > 10 mmHg in systolic blood pressure during inspiration)?

The proteasome inhibitor Carfilzomib, used in the treatment of multiple myeloma, is notoriously associated with which severe cardiovascular toxicity?

When interpreting the results of an intravascular ultrasound (IVUS) in the Left Main Coronary Artery, what Minimum Lumen Area (MLA) cut-off generally supports the decision to defer percutaneous intervention because the lesion is considered hemodynamically non-significant?

The presence of “Kussmaul’s Sign” during physical examination (a paradoxical rise in jugular venous pressure during inspiration) is indicative of right heart failure and is classically associated with which condition?

Mavacamten is a novel, first-in-class therapy FDA-approved for symptomatic Hypertrophic Obstructive Cardiomyopathy (HOCM). What is its specific mechanism of action?

In the management of Atrial Fibrillation, the CABANA trial compared catheter ablation to medical therapy. What was the primary conclusion regarding mortality and stroke endpoints?